歌礼制药-B(01672)10月31日耗资约193.27万港元回购20万股
ASCLETISASCLETIS(HK:01672) 智通财经网·2025-10-31 10:58

Core Viewpoint - Company Gilead Sciences-B (01672) announced a share buyback plan, intending to repurchase 200,000 shares at a cost of approximately HKD 1.9327 million by October 31, 2025 [1] Summary by Category - Company Actions - Gilead Sciences-B plans to repurchase 200,000 shares [1] - The total expenditure for the buyback is estimated at HKD 1.9327 million [1]